Janssen: Przemysław Bosak
Janssen: Cyril Titeux
Cyril and PB will share their views on the future outlook of our region and EMEA in the context of pharma. You will have an opportunity to ask questions to both gentlemen. Please come and join us!
For J&J employees
Thursday, 23 May 2019
9:00 AM
Several lecturers
Saturday, 13 April 2019
9:00 AM
Janssen Christian Rodseth
Janssen: Martin Price
Innovative medicine development is a complex process. Build a story around it in order to explain the drug pricing issue.
For J&J employees
Monday, 3 December 2018
2:00 PM
Prof. Milan Lukáš, MD, Ph.D,
Prof. Milan Lukáš z punktu widzenia praktyka porusza następujące tematy:
Thursday, 25 October 2018
12:30 PM
Prof. Grażyna Rydzewska, MD, Ph.D
Mechanizmy działania nowych leków w chorobie Leśniowskiego-Crohn’a wraz z omówieniem skuteczności i bezpieczeństwa ustekinumabu w indukowaniu remisji klinicznej i poprawie stanu pacjentów z chorobą Leśniowskiego-Crohn’a.
Wednesday, 3 October 2018
2:00 PM
Prof. Piotr Wysocki
Prof. Heather Payne
dr Stefan Hinz
Patients with metastatic prostate cancer are a heterogeneous group. Some of them, diagnosed at an early stage of the disease, went through other stages and could receive different types of therapy. Others were diagnosed at the metastatic stage.
Friday, 21 September 2018
4:45 PM
Prof. Stephen M. Stahl
In this workshop, renowned psychiatrist Dr. Stephen M. Stahl will discuss the underlying neurological alterations in schizophrenia, mechanisms of antipsychotic agents...
Saturday, 30 June 2018
12:30 PM
Prof. Stephen M. Stahl
In this workshop, renowned psychiatrist Dr. Stephen M. Stahl will discuss the underlying neurological alterations in schizophrenia, mechanisms of antipsychotic agents...
Saturday, 30 June 2018
8:30 AM
Several lecturers
During the meeting our speakers will discuss about the importance of early interventions in the disease course followed by practical examples.
Friday, 29 June 2018
12:30 PM
